DSP Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • (-1.57%)Nav, as on 19-03-2026

  • Previous Nav

  • Net Change on 19-03-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
DSP Healthcare Fund - Direct Plan - Growth -2.36 -5.10 0.91 22.94 16.31 21.26
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 0.91 22.94 16.31 0.65 3,033.42
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 6.32 24.48 17.20 0.91 8,306.35
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 6.31 28.46 18.81 1.04 6,801.16
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 5.55 26.33 19.06 0.91 4,076.67
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 10.29 26.83 18.36 0.47 2,843.74
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 5.33 24.98 17.50 0.69 1,300.81

Fund Holdings as on 28-February-2026

  • Sun Pharmaceutical Industries Limited

  • IPCA Laboratories Limited

  • Cipla Limited

  • Globus Medical Inc

  • Laurus Labs Limited

  • Illumina Inc

  • Sai Life Sciences Limited

  • Gland Pharma Limited

  • Apollo Hospitals Enterprise Limited

  • Alembic Pharmaceuticals Limited

  • Pfizer Limited

  • Vijaya Diagnostic Centre Limited

  • Cohance Lifesciences Limited

  • Kovai Medical Center and Hospital Limited

  • Intuitive Surgical Inc

  • Procter & Gamble Health Limited

  • Indoco Remedies Limited

  • Concord Biotech Limited

  • Emcure Pharmaceuticals Limited

  • ICICI Lombard General Insurance Company Limited

  • Nephrocare Health Services Limited

  • TREPS / Reverse Repo Investments

  • Abbott Laboratories

  • Aarti Drugs Limited

  • Unichem Laboratories Limited

  • Global X Funds - Global X Genomics & Biotechnology ETF

  • Alkem Laboratories Limited

  • Corona Remedies Limited

  • Medplus Health Services Limited

  • Jupiter Life Line Hospitals Limited

  • Laxmi Dental Limited

  • Grail Inc

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Insurance

  • Retailing

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹3,033.42 crore. DSP Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of DSP Healthcare Fund ended down ₹-0.64(-1.57%)yesterday to ₹40.211.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The DSP Healthcare Fund is managed by Chirag Dagli .

Fund House Contact

The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West) Mumbai - 400 028

+91 (22) 66578000
service@dspim.com
+91 (22) 66578181